Chengxue H. Qin

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Novel AT2R agonist, β-Pro7Ang III, is cardio- and vaso-protective in diabetic spontaneously hypertensive rats.

Novel AT2R agonist, β-Pro7Ang III, is cardio- and vaso-protective in diabetic spontaneously hypertensive rats.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 07, 2023

Targeting G protein-coupled receptors for heart failure treatment.

Targeting G protein-coupled receptors for heart failure treatment.

Journal: British journal of pharmacology

Published: October 26, 2022

Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.

Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.

Journal: Acta pharmacologica Sinica

Published: September 07, 2021

Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureus.

Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureus.

Journal: Nature communications

Published: May 20, 2020

Nitroxyl: A Novel Strategy to Circumvent Diabetes Associated Impairments in Nitric Oxide Signaling.

Nitroxyl: A Novel Strategy to Circumvent Diabetes Associated Impairments in Nitric Oxide Signaling.

Journal: Frontiers in pharmacology

Published: March 01, 2020

Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insights.

Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insights.

Journal: British journal of pharmacology

Published: November 06, 2018

Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.

Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.

Journal: Clinical science (London, England : 1979)

Published: January 30, 2017

Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes.

Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes.

Journal: Scientific reports

Published: May 23, 2016

New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury.

New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury.

Journal: Current drug targets

Published: March 19, 2015

Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.

Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.

Journal: Free radical biology & medicine

Published: November 19, 2014

Cardioprotective potential of annexin-A1 mimetics in myocardial infarction.

Cardioprotective potential of annexin-A1 mimetics in myocardial infarction.

Journal: Pharmacology & therapeutics

Published: November 14, 2014

Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.

Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.

Journal: Circulation. Heart failure

Published: August 08, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026